Lab
Centers Agency LLC
Centers Agency LLC was paid $11.41M by Medicaid between Feb 2019 and Jul 2021, across 133 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 69% of everything it billed.
33Billing provider infoCENTERS AGENCY LLC
BROOKLYN, NY 11219
BROOKLYN, NY 11219
33aNPI1508326851assigned 03/22/2019
33bProvider typeClinical Medical Laboratory
28Total paid$11.41M
24GClaims585,901
24DCodes billed133
24AFirst – last monthFeb 2019 – Jul 2021
Compared with peers
Next to other Clinical Medical Laboratory providers in New York
Rank by total paid#20 of 116
Median peer was paid$618K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 91,356 | $502K | |
| 2020 | 268,918 | $5.42M | |
| 2021 | 225,627 | $5.49M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 69% | 104,562 | 36,326 | $7.83M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 10% | 56,275 | 16,580 | $1.15M |
| 80053 | Comprehensive metabolic panel | 2.3% | 39,211 | 30,144 | $266K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.9% | 8,162 | 7,701 | $220K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.4% | 19,754 | 18,408 | $161K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 60,975 | 40,399 | $155K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 22,350 | 13,311 | $115K |
| 87631 | <1% | 1,322 | 1,084 | $99K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13,937 | 12,723 | $96K |
| 83880 | <1% | 2,319 | 1,627 | $58K | |
| 86769 | <1% | 1,895 | 1,835 | $57K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,370 | 663 | $57K |
121 more codes
| 82607 | <1% | 6,083 | $56K | |
| 87088 | <1% | 7,679 | $55K | |
| 80050 | General health panel | <1% | 2,829 | $45K |
| 80061 | Lipid panel | <1% | 17,911 | $44K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 18,265 | $43K |
| 85610 | <1% | 13,240 | $42K | |
| 80177 | <1% | 4,213 | $38K | |
| 87556 | <1% | 1,297 | $38K | |
| 80164 | <1% | 3,924 | $35K | |
| 87561 | <1% | 1,271 | $33K | |
| 84439 | <1% | 4,896 | $32K | |
| 82728 | <1% | 4,115 | $28K | |
| 84153 | <1% | 1,620 | $27K | |
| 87496 | <1% | 1,299 | $25K | |
| 87077 | <1% | 3,067 | $25K | |
| 82746 | <1% | 4,497 | $25K | |
| 80202 | <1% | 3,166 | $24K | |
| 87503 | <1% | 1,293 | $22K | |
| 87653 | <1% | 1,177 | $22K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 41,589 | $21K |
| 84466 | <1% | 2,313 | $20K | |
| 87498 | <1% | 1,298 | $20K | |
| 87640 | <1% | 1,179 | $20K | |
| 87581 | <1% | 1,210 | $20K | |
| 87486 | <1% | 1,290 | $19K | |
| 87500 | <1% | 1,293 | $19K | |
| 87184 | <1% | 3,066 | $17K | |
| 81001 | <1% | 6,509 | $17K | |
| 82140 | <1% | 1,228 | $16K | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 15,524 | $14K |
| 82248 | <1% | 4,128 | $14K | |
| 83970 | <1% | 353 | $14K | |
| 87040 | <1% | 1,425 | $12K | |
| 86140 | <1% | 4,083 | $12K | |
| 84134 | <1% | 2,158 | $12K | |
| 83540 | <1% | 4,316 | $10K | |
| 80185 | <1% | 1,084 | $10K | |
| 87075 | <1% | 1,291 | $9K | |
| 86803 | <1% | 1,324 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 233 | $9K |
| 87493 | <1% | 594 | $8K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,066 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,173 | $7K |
| 84480 | <1% | 3,543 | $7K | |
| 83735 | <1% | 2,413 | $7K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 6,495 | $7K |
| 86780 | <1% | 735 | $7K | |
| 87252 | <1% | 267 | $6K | |
| 85730 | <1% | 1,395 | $6K | |
| 87481 | <1% | 1,247 | $6K | |
| 80076 | <1% | 1,108 | $5K | |
| 86706 | <1% | 926 | $5K | |
| 85651 | <1% | 3,257 | $5K | |
| 83090 | <1% | 335 | $5K | |
| 83550 | <1% | 3,216 | $4K | |
| 87536 | <1% | 73 | $4K | |
| 87541 | <1% | 1,199 | $4K | |
| 86708 | <1% | 793 | $4K | |
| 87340 | <1% | 861 | $4K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 27 | $4K |
| 84100 | <1% | 1,292 | $4K | |
| 83615 | <1% | 978 | $3K | |
| 86705 | <1% | 788 | $3K | |
| 84550 | <1% | 940 | $3K | |
| 81002 | <1% | 1,487 | $3K | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 4,727 | $3K |
| 86709 | <1% | 747 | $3K | |
| 86704 | <1% | 893 | $3K | |
| 80178 | <1% | 424 | $2K | |
| 84436 | <1% | 1,626 | $2K | |
| 86480 | <1% | 82 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 250 | $2K |
| 80184 | <1% | 206 | $2K | |
| 84681 | <1% | 110 | $2K | |
| 86360 | <1% | 56 | $2K | |
| 82947 | <1% | 544 | $2K | |
| 82550 | <1% | 547 | $2K | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 414 | $2K |
| 82040 | <1% | 435 | $2K | |
| 83690 | <1% | 371 | $1K | |
| 85044 | <1% | 1,449 | $1K | |
| 87205 | <1% | 450 | $1K | |
| 81376 | <1% | 28 | $1K | |
| 82378 | <1% | 59 | $1K | |
| 87522 | Neg quan hep c or qual rna | <1% | 30 | $1K |
| 85379 | <1% | 138 | $988.41 | |
| 82150 | <1% | 326 | $982.78 | |
| 80156 | <1% | 103 | $937.20 | |
| 80162 | <1% | 136 | $919.90 | |
| 84132 | <1% | 176 | $578.32 | |
| 82272 | <1% | 368 | $553.58 | |
| 84484 | <1% | 125 | $514.81 | |
| 87449 | <1% | 174 | $495.44 | |
| 82565 | <1% | 221 | $439.42 | |
| 84520 | <1% | 205 | $427.60 | |
| 84145 | <1% | 32 | $359.74 | |
| 82784 | <1% | 77 | $355.00 | |
| 82570 | <1% | 198 | $353.50 | |
| 82310 | <1% | 147 | $335.90 | |
| 86255 | <1% | 142 | $291.10 | |
| 82977 | <1% | 89 | $284.88 | |
| 86141 | <1% | 34 | $258.53 | |
| 82043 | <1% | 84 | $245.62 | |
| 85378 | <1% | 48 | $230.19 | |
| 86021 | <1% | 69 | $223.13 | |
| 83516 | <1% | 89 | $194.99 | |
| 86812 | <1% | 25 | $165.94 | |
| 82553 | <1% | 50 | $165.85 | |
| 87045 | <1% | 26 | $156.74 | |
| 86430 | <1% | 28 | $95.61 | |
| 80299 | <1% | 18 | $90.49 | |
| 86038 | <1% | 53 | $86.28 | |
| 85348 | <1% | 50 | $74.92 | |
| 82374 | <1% | 32 | $58.35 | |
| 86592 | <1% | 14 | $44.51 | |
| 80051 | <1% | 12 | $37.37 | |
| 84295 | <1% | 48 | $33.78 | |
| 82435 | <1% | 31 | $24.97 | |
| 86671 | <1% | 12 | $5.54 | |
| 99080 | 0% | 1,983 | $0.00 | |
| 85008 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROZENBERG, KENNETH (MEMBER)
| Provider | Location | Paid |
|---|---|---|
| Centrek Transportation LLC | Bronx, NY | $118.02M |
| Bronx Center for Renal Dialysis LLC | Bronx, NY | $2.63M |
| Otsego SNF Operations Assoc LLC | Cooperstown, NY | $840K |
| Wartburg Receiver LLC | Ridgewood, NY | $774K |
| SV Operating Three LLC | Staten Island, NY | $664K |
| Wartburg Receiver LLC | Brooklyn, NY | $523K |
| Bronx Center for Renal Dialysis LLC | Brooklyn, NY | $154K |
| Wartburg Receiver, LLC | Brooklyn, NY | $55K |
| Prospect Park Operating, LLC | Brooklyn, NY | $18K |
| Boro Park Operating Co LLC | Brooklyn, NY | $193.12 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.